S2Medical AB (publ) (STO:S2M)
Sweden · Delayed Price · Currency is SEK 0.0060
0.00 (0.00%)
Aug 12, 2026, 5:22 PM CET
S2Medical AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5 | 10 | 9 | 13 | 6 | 58 | |
Market Cap Growth | -47.18% | 9.45% | -30.39% | 116.80% | -89.93% | -33.19% |
Enterprise Value | 4.53 | 8.8 | 7.86 | 11.22 | 2.15 | 49.06 |
Last Close Price | 0.01 | 0.01 | 0.01 | 0.05 | 0.18 | 3.88 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 1.05 | - | - | - |
PS Ratio | 0.34 | 0.57 | 0.40 | 1.51 | 0.66 | 5.07 |
PB Ratio | 0.55 | 0.98 | 0.47 | 7.68 | 0.83 | 3.97 |
P/TBV Ratio | - | - | 0.84 | - | - | 19.09 |
P/FCF Ratio | 8.05 | 14.35 | 1.76 | - | - | - |
P/OCF Ratio | 8.05 | 14.35 | 1.76 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.28 | 0.52 | 0.35 | 1.33 | 0.24 | 4.27 |
EV/EBITDA Ratio | - | - | 1.28 | - | - | - |
EV/EBIT Ratio | - | - | 1.63 | - | - | - |
EV/FCF Ratio | 6.70 | 13.01 | 1.56 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Debt / Equity Ratio | -0.09 | -0.09 | -0.05 | -0.91 | -0.53 | -0.63 |
Net Debt / EBITDA Ratio | 0.65 | 0.65 | -0.16 | 0.11 | 0.14 | 0.51 |
Net Debt / FCF Ratio | -1.34 | -1.34 | -0.20 | 0.09 | 0.13 | 0.47 |
Asset Turnover | 0.80 | 0.80 | 0.96 | 0.36 | 0.32 | 0.32 |
Inventory Turnover | 0.65 | 0.65 | 0.23 | 0.37 | 0.47 | 0.89 |
Quick Ratio | 0.26 | 0.26 | 0.50 | 0.17 | 0.29 | 0.72 |
Current Ratio | 0.56 | 0.56 | 0.87 | 0.44 | 0.65 | 1.08 |
Return on Equity (ROE) | -70.61% | -70.61% | 47.23% | -520.38% | -270.86% | -84.27% |
Return on Assets (ROA) | -12.61% | -12.61% | 20.65% | -65.37% | -100.74% | -55.77% |
Return on Invested Capital (ROIC) | -29.70% | -19.97% | 54.08% | -875.41% | -632.44% | -285.54% |
Return on Capital Employed (ROCE) | -18.63% | -18.63% | 47.39% | -349.80% | -254.61% | -82.89% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | - | - | 95.24% | - | - | - |
FCF Yield | 12.43% | 6.97% | 56.75% | - | - | - |
Buyback Yield / Dilution | -53.03% | -53.03% | -360.86% | -411.02% | -60.30% | -26.41% |
Total Shareholder Return | -53.03% | -53.03% | -360.86% | -411.02% | -60.30% | -26.41% |